All analyses
AI analysis

Co-operative Insurance Company PLC: research report

Moderately overvaluedbearishNov 15, 2026

Evidence points bearish: COOP trades at 19.4 times earnings, well above insurance peers, while revenue has fallen. The counterweight is a 0.82-times book valuation, the sector's cheapest.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bearish

  • The P/E is 19.4 times versus the insurance-sector median of 12.19 times, despite a 4.4% return on equity in the latest audited year.
  • The share offers a 0.0% trailing dividend yield versus a 7.1% sector median, leaving the valuation reliant on retained earnings.
  • September-quarter revenue fell 1.3% year-on-year, even as profit increased 16.7% from a low base.

Against this. At 0.82 times book value, the share is the cheapest in the insurance peer set and cheaper than 72% of its own trading days since December 2021.

Net margin
4.4%sector 1.4%
from 3.8% a year earlier, revenue -1.3%
Return on equity
4.4%sector 7.2%
full year to Dec 31, 2025
P/E
18.8sector 15.6
earnings Rs 0.17 per share, year to Dec 2025
P/B
0.80sector 1.46
book Rs 4.01 per share
Dividend yield
0.00%sector 1.83%
trailing twelve months

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 15, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

Co-operative Insurance is a nationwide life and general insurer serving cooperative-sector and financially underserved customers through branches, service centres and partner networks. The latest quarter showed higher profit despite lower revenue, but the available figures do not separate whether that improvement came from underwriting operations or items below operating profit.

Price performance

COOP closed at LKR 3.30 on 13 November 2026. It fell 8.3% over three months while the ASPI gained 1.9%, and its 36.5% one-year fall compares with a 4.7% decline in the index, showing substantial underperformance over both periods.

The price sits 20.8% of the way from its 52-week low to high, so it remains near the lower end of its own annual range. The three-year record contains four falls of 15% or more, with the deepest decline still unrecovered. Median daily turnover was LKR 1.2 million; a LKR 1 million order is about 84% of what trades on a typical day, a large part of a day's trading.

Valuation

The P/E is 19.4 times, meaning the market price is LKR 19.40 for every LKR 1 of trailing profit, against a 12.19-times insurance-sector median. That premium is difficult to reconcile with the latest audited return on equity of 4.4%, which measures the profit generated from shareholders' capital.

The P/B is 0.82 times, or 82 cents for each rupee of net assets, and is the lowest among 11 insurance peers. It is also cheaper than 72% of days since December 2021. This is the principal valuation offset to the high P/E: the market is valuing the balance sheet below book, but placing a relatively high price on current earnings.

The trailing dividend yield is 0.0%, compared with a sector median of 7.1%. The recorded payout was LKR 0.05 per share in FY2024 versus LKR 0.135 in FY2021, with no dividends recorded for the intervening financial years. A dividend has been announced but has no ex-date.

News and sentiment

Coverage was normal rather than unusually loud: four material articles appeared over the past 90 days, comprising one positive and three neutral items. The main corporate item was the redemption of LKR 16.61 million of cumulative redeemable preference shares, reported on 4 September 2026; these are preference shares, not ordinary shares, and do not alter the ordinary share count.

The dividend remains an unresolved corporate-action item. It was announced on 2 January 2026 and still has no ex-date, so its timing and whether it becomes available to ordinary shareholders cannot be established from the current record.

Financials

September-quarter revenue was LKR 1.7 billion, down 1.3% year-on-year, while net profit rose 16.7% to LKR 73.8 million. The business therefore produced more profit from a slightly smaller revenue base, but the latest filing does not provide gross or operating profit, so the source of the improvement cannot be separated between underwriting operations and below-the-line items.

Gross and operating margins are not available for the September 2026 quarter. Net margin was 4.4%, versus 3.8% a year earlier, meaning the company retained about four cents of profit from each rupee of revenue. This was middling for a September quarter, ranking third out of five comparable filings, rather than an unusually strong result.

Equity rose to LKR 6.6 billion from LKR 6.1 billion a year earlier, while the filing used 1.65 billion ordinary shares, unchanged from the latest balance-sheet share count. The per-share data therefore does not reflect a mechanical change from an ordinary-share issue or subdivision.

Risks

The largest balance-sheet risk is the insurer's leverage through policy and other liabilities. At the latest audited year-end, liabilities were 2.05 times equity, up from 1.93 times a year earlier. For an insurer these liabilities include policy-related obligations, but the increase means each rupee of shareholder capital supports more obligations than before.

Earnings quality is also hard to assess from the latest quarter because operating profit and the below-the-line bridge are unavailable, while revenue declined. The share's liquidity adds a practical risk: median daily turnover was only LKR 1.2 million, making a LKR 1 million transaction a large part of a normal session.

Industry conditions add uncertainty. Falling government bond yields can lift fixed-income portfolio values while reducing reinvestment yields, and the weaker rupee can raise foreign-currency reinsurance costs. These are sector conditions, not company-specific developments.

Outlook

As at 15 November 2026, the next defined information event is the audited year-end filing for 31 December 2026, expected between 28 April and 3 June 2027. It will supersede the September-quarter figures and clarify whether profit growth was supported by underlying insurance operations despite the revenue decline.

The other unresolved item is the dividend announced on 2 January 2026 without an ex-date. The current data cannot establish its timing, amount or whether the historical lack of a trailing yield will change. There is also one older announced event beyond its usual timing window, which remains a corporate-action uncertainty rather than an upcoming scheduled event.

About this report. Generated on Nov 15, 2026 from market data up to Nov 13, 2026, 4 material news articles over 90 days and financials to Sep 30, 2026, and scored 35 of 100 on value (moderately overvalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports